Pre-made Omalizumab benchmark antibody ( Whole mAb, anti-IGHE/IgE therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-398

Pre-Made Omalizumab biosimilar, Whole Mab: Anti-IGHE/IgE therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Omalizumab, sold under the brand name Xolair, is a medication used to treat asthma, nasal polyps, and urticaria.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-398-1mg 1mg 3090 30% 2163

Size: 1mg | 10mg | 100mg



Description

Products Name (INN Index) Pre-Made Omalizumab biosimilar, Whole Mab: Anti-IGHE/IgE therapeutic antibody
INN Name Omalizumab
TargetIGHE
FormatWhole mAb
Derivation
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Approved
Est. StatusActive
100% SI Structure4x7s:HL/2xa8:HL/4x7t:HL:AB/5hys:HL:AB:EF:CD/6tcm:HL/6tcn:HL/6tco:BA/6tcp:HL
99% SI Structure5g64:IM:HL
95-98% SI StructureNone
Year Proposed2000
Year Recommended2001
CompaniesDana-Farber Cancer Institute;Genentech;John Hopkins University;Novartis
Conditions ApprovedAllergic asthma;Urticaria
Conditions ActiveSeasonal allergic rhinitis;Nasal polyps;Mastocytosis;Asthma;Nephritis
Conditions DiscontinuedHypersensitivity;Peanut hypersensitivity
Development Techna